Real-time continuous glucose monitoring in preterm infants (REACT): an international, open-label, randomised controlled trial

Background Hyperglycaemia and hypoglycaemia are common in preterm infants and have been associated with increased risk of mortality and morbidity. Interventions to reduce risk associated with these exposures are particularly challenging due to the infrequent measurement of blood glucose concentratio...

Full description

Bibliographic Details
Main Authors:	Beardsall, K, Thomson, L, Guy, C, Iglesias-Platas, I, van Weissenbruch, MM, Bond, S, Allison, A, Kim, S, Petrou, S, Pantaleo, B, Hovorka, R, Dunger, D, Molnar, Z, Barlow, S, Baugh, S, Johnson, K, Uryn, L, Spencer, C, Hubbard, M, Somisetty, S, Adesiyan, O, Kapadia, J, Millar, Y, Gurusamy, K, Bibb, L, Jones, K, Heaver, R, Muthukumar, P, Nichols, A, Johnson, M, Pond, J, Crowley, P, Mellish, C, Shah, DD, Abraham, M, Vincent, P, Anil kumar, S, Iringan, A, Aninakwa, B, Dalangin-Chalmers, RA, de Lange, A
Format:	Journal article
Language:	English
Published:	Elsevier 2021

Real-time continuous glucose monitoring in preterm infants (REACT): an international, open-label, randomised controlled trial

Similar Items